The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
AUTOR(ES)
Zach, M. S.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=472501Documentos Relacionados
- Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
- In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
- DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.
- Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
- Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.